The global market for vaccine technologies reached $35.7 billion in 2017 and should reach nearly $46.6 billion by 2022, at a compound annual growth rate (CAGR) of 5.5% for the period of 2017-2022.Reports Highlights, Global Markets for Vaccine Technologies, BCC


Enterprise Ireland clients have access to the following reports on the Vaccine market. To access these reports, you can contact the Market Research Centre at We’re open from 9am-5pm, Monday to Friday.


You can view the list of our resources at this link.


• Global Markets for Vaccine Technologies, 2018
• The Global Influenza Market


• Datamonitor has multiple reports of various vaccines such as Meningococcal Vaccines, Pneumococcal Vaccines and Dengue DNA Vaccine. They have separate reports on the Pipeline, Forecast and Marketed drugs for these vaccines.


Frost and Sullivan
• Advances in Vaccines, Energy Harvesting, Smartphones and Water Treatment.
• Innovations in Stem Cell-based Implants, ALS Treatment, CRISPR, and Personalized Cell Vaccines
• Innovations in Predictive 3D Modeling of Live Human Cells, Vaccine Development, Gene Editing, and Targeted Protein Degradation Platforms
• Innovations in Stretchable Biosensors, Implantable Neurostimulators, Needle-free Vaccine Delivery, and Nanomaterials


• Pharmaceuticals


• Contract Injection Molding Manufacturing in the US
• Syringes & Injection Needle Manufacturing in the US


• Pharmaceuticals
• OTC Pharmaceuticals


• The Latest in Vaccine Policies: Selected Issues in School Vaccinations, Healthcare Worker Vaccinations, and Pharmacist Vaccination Authority Laws. By: Barraza, Leila; Schmit, Cason; Hoss, Aila. Journal of Law, Medicine & Ethics. 2017 Supplement, Vol. 45

• Emergency Preparedness in the Workplace: The Flulapalooza Model for Mass Vaccination. By: Swift, Melanie D.; Aliyu, Muktar H.; Byrne, Daniel W.; Keqin Qian; McGown, Paula; Kinman, Patricia O.; Hanson, Katherine Louise; Culpepper, Demoyne; Cooley, Tamara J.; Yarbrough, Mary I. American Journal of Public Health. 2017 Supplement2, Vol. 107

• Political and regulatory key factors of transparency and independence in terms of vaccination in Spain: Information, participation and lobbies. By: Cuenca, Nuria María Garrido. Pharmaceuticals Policy & Law. 2017, Vol. 19 Issue ½

• Fostering InterproFessional Education Through a Multidisciplinary, Community-Based Pandemic Mass Vaccination Exercise. By: Hays, Annette; Schriever, Christopher; Rudzinski, John; Lynch, Janet L.; Genrich, Ellen; Schriever, Allison. American Journal of Public Health. Mar2018, Vol. 108 Issue 3


Note: All databases are subject to copyright. The use of cameras and USBs is strictly prohibited.